DarioHealth extends mandatory conversion period for Series C preferred stock from 15 to 24 months

DarioHealth Corp.

Mandatory conversion period extended from 15 to 24 months for Series C, C-1, C-2 preferred stock.
Preferred holders will receive a quarterly dividend of 15% of common shares issuable upon conversion.
No new securities were issued or sold as a result of the amendment.
Amended and restated certificates of designation filed on May 20, 2025.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.